AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ORLISTAT
9 registrations across 5 African markets— 9 active
Markets with ORLISTAT
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Reeshape Capsules Capsule | 🇳🇬Nigeria | Adler Products Ltd | active | Mar 2029 |
| Orlifit 120 Capsules Capsule | 🇳🇬Nigeria | Getz Pharma Nigeria Limited | active | Nov 2025 |
| XENICAL | 🇿🇦South Africa | Pharmaco Distribution (Pty) Ltd | active | Jan 1900 |
| XENICAL gélule / 120 ml | 🇸🇳Senegal | ROCHE REGISTRATION LIMITED | active | — |
| XENICAL gélule / B/84 | 🇸🇳Senegal | RHOCHE | active | — |
| ORLISTAT ORAL SOLID
ORDINARY
CAPSULES | 🇺🇬Uganda | INTAS PHARMACEUTICA LS LIMITED | active | — |
| XENICAL GELULE | 🇲🇦Morocco | — | active | — |
| XENICAL GELULE | 🇲🇦Morocco | — | active | — |
| ORLISTAT ORAL SOLID
ORDINARY
CAPSULES | 🇺🇬Uganda | INTAS PHARMACEUTICA LS LIMITED | active | — |
ORLISTAT in Africa — Regulatory Overview
ORLISTAT is registered across 5 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Nigeria, Senegal, Uganda and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.